Topical photodynamic therapy with porphyrin precursors—assessment of treatment-associated pain in a retrospective study
- 10 June 2009
- journal article
- research article
- Published by Springer Nature in Photochemical & Photobiological Sciences
- Vol. 8 (8) , 1111-1116
Abstract
Photodynamic therapy (PDT) with aminolevulinic acid (ALA) or methyl aminolevulinate (MAL) is an approved modality for the non-invasive treatment of actinic keratoses (AK) and basal cell carcinoma (BCC) offering excellent cosmetic outcome. However, pain during and after illumination is the most frequent and limiting side effect. The aim of this study was to precisely assess how reported pain during PDT is influenced by sex, age, treatment site, disease (AK/BCC) as well as the photosensitizer used. 467 lesions consisting of AK (primary treatments: n = 158; follow-up: n = 47) or BCC (primary treatments: n = 138; follow-up: 124) were treated by ALA- or MAL-PDT using metal halide lamps (580–750 nm). Pain was assessed during illumination using a continuous visual analogue scale (VAS). Factors predictive for higher pain levels during PDT are treatment of the head, treating AK and using ALA. The observed results may improve patient management and predict which level of pain to expect, and what kind of pain relief to prepare.Keywords
This publication has 29 references indexed in Scilit:
- Photodynamic Therapy in Dermatology – an Update 2008JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2008
- Comparative benefit of two thermal spring waters after photodynamic therapy procedureJournal of Cosmetic Dermatology, 2007
- Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow upBritish Journal of Dermatology, 2006
- Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled studyBritish Journal of Dermatology, 2006
- Morphine Gel 0.3% Does Not Relieve Pain During Topical Photodynamic Therapy: A Randomized, Double-blind, Placebo-controlled StudyActa Dermato-Venereologica, 2006
- Randomized, double-blind, placebo-controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2·5% and prilocaine 2·5% for topical 5-aminolaevulinic acid-photodynamic therapy for extensive scalp actinic keratosBritish Journal of Dermatology, 2005
- Photodynamic therapy in dermatology – an updatePhotodermatology, Photoimmunology & Photomedicine, 2005
- Topical photodynamic therapy in the treatment of actinic keratoses and Bowen’s disease in transplant recipientsTransplantation, 2004
- Clinical efficacy of methyl aminolevulinate (Metvix®) photodynamic therapyJournal of Dermatological Treatment, 2003
- Realizing the cosmetic potential of topical photodynamic therapyJournal of Cosmetic Dermatology, 2002